FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083287 [Registered on: 24/03/2025] Trial Registered Prospectively
Last Modified On: 23/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   A study on patients diagnosed with psychotic disorders to know antipsychotic drug use pattern . 
Scientific Title of Study   A Descriptive Observational Study on Prescribing Pattern of Antipsychotic Drugs Among Outpatients Attending Department of Psychiatry at Sawai Man Singh Medical College, and Attached Hospitals, Jaipur 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Anjali Beserwal 
Designation  Resident Doctor 
Affiliation  Sawai Man Singh Medical College 
Address  Department of Pharmacology, SMS Medical College, JLN Marg,Jaipur, Rajasthan

Jaipur
RAJASTHAN
302004
India 
Phone  8005870543  
Fax    
Email  anjalibeserwal1@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Rupa Kapadia 
Designation  Professor 
Affiliation  Sawai Man Singh Medical College 
Address  Department of Pharmacology, SMS Medical College, JLN Marg,Jaipur, Rajasthan

Jaipur
RAJASTHAN
302004
India 
Phone  9929871911  
Fax    
Email  drrupakapadia@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Anjali Beserwal 
Designation  Resident Doctor 
Affiliation  Sawai Man Singh Medical College 
Address  Department of Pharmacology, SMS Medical College, JLN Marg,Jaipur, Rajasthan

Jaipur
RAJASTHAN
302004
India 
Phone  8005870543  
Fax    
Email  anjalibeserwal1@gmail.com  
 
Source of Monetary or Material Support  
SMS Medical College and Hospital, JLN Marg, Adarsh Nagar, Jaipur, Rajasthan, India Pincode - 302004 
 
Primary Sponsor  
Name  Anjali Beserwal 
Address  Sawai Man Singh Medical College,Jaipur,Rajasthan,India Pincode -302004 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Anjali Beserwal  Sawai Man Singh Hospital  Outpatient department, Department of Psychiatry, Sawai Man Singh Hospital, Jaipur, Rajasthan
Jaipur
RAJASTHAN 
8005870543

anjalibeserwal1@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics Committee, SMS Medical College and Attached Hospitals, Jaipur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F20-F29||Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1. Newly diagnosed patients of psychosis prescribed with atleast one antipsychotic drug.
2. Patients of age above 18 years of either sex.
3. Patients willing to participate and give written informed consent. 
 
ExclusionCriteria 
Details  1. Critically ill,non-cooperative patients.
2. Patients diagnosed with organic disorders caused due to brain trauma, blood loss and diseases like Parkinson disease and Alzheimer disease. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.Average number of drugs per prescription.
2.Percentage of drugs prescribed with generic name.
3.Percentage of drugs prescribed from the National Essential Drug List ( NEDL),2022.
4.Percentage of prescriptions with antibiotics prescribed.
5.Percentage of prescriptions with injections prescribed.  
1. 6 months
2. 6 months
3. 6 months
4. 6 months
5. 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
1. Classification of drugs according to the Anatomical Therapeutic Chemical
Classification.
2.Calculation of Daily Defined Dosage of prescribed drugs.
3.Percentage of patients having effect on the mental health and quality of life being prescribed antipsychotic drugs by using MHQOL-7D Questionnaire.  
1. 6 months
2. 6 months
3. 6 months 
 
Target Sample Size   Total Sample Size="400"
Sample Size from India="400" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   04/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The purpose of study is to evaluate the drug prescribing pattern of antipsychotic drugs as per WHO core indicators in outpatient department of psychiatry,  SMS College and Attached Hospital . The study will give an insight to understand the prescribing pattern of antipsychotic drugs and to assess the mental health and quality of life in patients being prescribed with antipsychotic drugs attending the Outpatient Department of Psychiatry.  
Close